A Minimalist Design Looks Great for Clearing Tau
Interception of Extracellular Tau by Antibodies May Be Sufficient to Stop the Spread of Tau in AD
Spherical Nucleic Acids Deliver a New Package for Oliognucleotide Therapeutics
SNAs Are a Hopeful First Step in Boosting the Utility of Oligonucleotides to Treat a Variety of Human Diseases
Downstream Issues Still Beset Production
To Protect the Bottom Line, Biomanufacturers Invest in Downstream Purification Technology
GEN Roundup: No Detail Is Too Small in Bioprocess Scaleup
A Change in Scale Can Change Everything
GEN’s editor in chief, John Sterling, interviews life science academic and biotech industry leaders on important research, technology, and trends. These podcasts will keep you informed with all the important details you need.
Mary Woolley, President of Research!America, which advocates for medical and health research funding, discusses key issues in research that the next president is likely to confront. How can researchers keep those issues on the national agenda no matter who wins on Election Day?
A new study from investigators at The Ohio State University entitled “Gut dysbiosis impairs recovery after spinal cord injury,” describes the impact the gut microbiome has on spinal cord injury and how probiotics could help speed recovery.
One area where biopharma employment has been increasing is in regulatory affairs and compliance.
Quadruple helices appear to have role in switching genes on or off.
Yale University researchers have uncovered the intriguing mechanisms that underlie common sickness behaviors.
Interview with Jon Soderstrom, Ph.D., managing director of the office of cooperative research at Yale University and moderator of the BIO tech transfer session, and Atul Saran, senior vp of corporate development and ventures at MedImmune
Interview with Jim Vaught, Ph.D., Deputy Director, NCI Office of Biorepositories and Biospecimen Research
Alan Russell, Ph.D., Editor in Chief
E. Morrey Atkinson, Ph.D., CSO, VP of R&D, Cook Pharmica
Jeffrey Karp, Ph.D., Co-Director, Center for Regenerative Therapeutics; Associate Bioengineer, Brigham and Women’s Hospital; and Assistant Professor, Harvard Medical School
Gholson Lyon, M.D., Ph.D., Senior Scientist, Principal Investigator, Center for Applied Genomics, The Children’s Hospital of Philadelphia
Benjamin Schuler, Ph.D., Professor of Biochemistry, University of Zurich
G. Steven Burrill, CEO, Burrill & Company
Sandy M. Simon, Ph.D., Professor, Laboratory of Cellular Biophysics, The Rockefeller University
Dr. Jessica Winter, Assistant Professor, Chemical and Biomolecular Engineering and Biomedical Engineering, Ohio State University
Aris Persidis, Ph.D., President, Biovista
Mark G. Fromhold, Ph.D., Vice President, Manufacturing & Business Development, Koronis Pharmaceuticals
Kenneth J. Shea, Ph.D., Professor, Chemistry, School of Physical Sciences, University of California, Irvine
Drew Endy is an assistant professor of bioengineering at Stanford University. He earned a BS and MS in civil and environmental engineering, respectively, from Lehigh University and a Ph.D. in biochemical engineering from Dartmouth College.
Anna Ziegler, an award-winning playwright, wrote Photograph 51, which looks at Rosalind Franklin’s essential role in the discovery of the double helix.